Progesterone Augmentation of Nicotine Replacement Therapy Study

NCT02685072 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Progesterone (200 mgs BID)
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]